Bolt Biotherapeutics, Inc. (BOLT)

SEC filing

Bolt Biotherapeutics, Inc.

BOLT · CIK 1641281

4 · Sep 21, 2026 · Director, President, CEO and CFO Quinn William P. bought 637 shares at $3.88/share ($2,469); sold 17.57K shares at $3.32/share ($58,402)

Director, President, CEO and CFO Quinn William P. bought 637 shares at $3.88/share ($2,469); sold 17.57K shares at $3.32/share ($58,402)

Filed: Sep 21, 2026
Period: Sep 16, 2026
Accession: 0001193125-26-396890
Filer: Bolt Biotherapeutics, Inc.

View on SEC.gov All SEC filings

Filing document

xslF345X06/ownership.xml

xslF345X06/ownership.xmlSEC.gov

Other files

Graphics and non-inline formats (not embedded below).

4ownership.xml
Open SEC.gov